As expected, the augmented TNF‐α, IL‐1β, IL‐6, and p‐p65 expression in the liver tissues of NAFLD mice caused by HFD treatment or in AML‐12 cells challenged with PA were all declined by Asprosin deficiency. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.